Figure 1

Recommendations for target definition according to EORTC, RTOG and ESTRO-ACROP
| Contouring approach | Dose prescription | GTV | CTV |
|---|---|---|---|
| EORTC single phase | 30 × 2.0 Gy | Resection cavity + residual T1 enhancement | GTV + 2 cm |
| RTOG two phases | 23 × 2.0 Gy | GTV1: Resection cavity + residual T1 enhancement + FLAIR abnormality (oedema) | CTV1 = GTV1 + 2 cm (the margin is 2.5 cm in cases where no oedema is presented) |
| + 7 × 2.0 Gy | GTV2: Resection cavity + residual T1 enhancement | GTV2 + 2 cm | |
| ESTRO-ACROP | 30 × 2.0 Gy | Resection cavity + residual T1 enhancement + FLAIR abnormality (oedema) for secondary glioblasomas | GTV + 2 cm |